Riskpilot← Back to searchSign inGet full accessNOVALAB2 AS
ASActiveOrg 925778044Karl Johans Gate 16, 0154 OsloRental and operating of own or leased real estate · NACE 6820Est. 20200 employees
Revenue 2025
NOK 0
EBITDA margin
—
+6% vs 2024
Equity ratio
94.5%
Financial strength
Net profit 2025
NOK -14K
+9% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -16K | +6% |
| Net profit | NOK -14K | +9% |
| Total assets | NOK 905K | -2% |
| Equity | NOK 855K | -2% |
| Employees | 0 | — |
Legal name
NOVALAB2 AS
Org number
925778044
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
12. oktober 2020
Share capital
NOK 628 815
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Deltakelse i andre virksomheter, investeringer i andre selskaper, og annet som står i forbindelse med dette.
Address
Karl Johans Gate 16, 0154 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −5 | −15 | −22 | −16 | −17 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −5 | −15 | −22 | −16 | −17 | −16 |
| Net financials | 0 | 0 | 1 | 0 | 1 | 1 |
| Profit before tax | −5 | −15 | −21 | −16 | −16 | −14 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −5 | −15 | −21 | −16 | −16 | −14 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 479 | 460 | 902 | 885 | 920 | 905 |
| Equity | 475 | 460 | 902 | 885 | 870 | 855 |
| Long-term debt | 0 | 0 | 0 | 0 | 50 | 50 |
| Short-term debt | 4 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 4 | 0 | 0 | 0 | 50 | 50 |
EBITDA margin
-1556900.0%
This company
15.8%
Market median
-9853897% vs market
20202025
Equity ratio
94.5%
This company
38.2%
Market median
+147% vs market
20202025
Return on equity
-1.7%
This company
18.4%
Market median
-109% vs market
20202025
Net profit margin
-1421000.0%
This company
8.1%
Market median
-17543310% vs market
20202025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KE Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Novalab As | Company | 51.1% | 51.1% | 2023 |
Hytten Invest As | Company | 4.2% | 4.2% | 2023 |
| Individual | 4.2% | 4.2% | 2023 | |
Sprettball As | Company | 2.5% | 2.5% | 2023 |
Ocius As | Company | 2.5% | 2.5% | 2023 |
Malmo Holding As | Company | 2.5% | 2.5% | 2023 |
Nimmt As | Company | 2.5% | 2.5% | 2023 |
| Individual | 2.5% | 2.5% | 2023 | |
Scorpius As | Company | 2.5% | 2.5% | 2023 |
Skape As | Company | 2.5% | 2.5% | 2023 |
Marianne K. Wahlstrøm Consulting As | Company | 2.5% | 2.5% | 2023 |
| Individual | 2.1% | 2.1% | 2023 | |
| Individual | 2.1% | 2.1% | 2022 | |
| Individual | 2.1% | 2.1% | 2023 | |
| Individual | 2.1% | 2.1% | 2023 | |
| Individual | 2.1% | 2.1% | 2023 | |
| Individual | 2.1% | 2.1% | 2023 | |
| Individual | 2.1% | 2.1% | 2022 | |
| Individual | 2.1% | 2.1% | 2023 | |
| Individual | 2.1% | 2.1% | 2022 | |
| Individual | 1.7% | 1.7% | 2023 | |
| Individual | 1.6% | 1.6% | 2023 | |
| Individual | 1.6% | 1.6% | 2023 | |
| Individual | 1.0% | 1.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nova Consulting Group As
NOVALAB2 AS Board members of NOVALAB2 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjetil Esten Haraldsson Manheim | Chief Executive Officer | 0 companies |